Welcome to your online cardiometabolic risk (CMR) resource center
designed to serve as a source of information to help maximize your knowledge of some key factors in the development of cardiometabolic risk: intra-abdominal adiposity (IAA) and the body’s endocannabinoid system (ECS). This resource will give you access to a variety of educational materials on IAA, ECS, and cardiometabolic risk, including:

	Intra-Abdominal Adiposity (IAA). A Multitude of Challenges. One Important, Informative Podcast. This Podcast describes IAA and its impact on the increasing prevalence of obesity, diabetes, cardiovascular disease (CVD), and more. Through clinical evidence and investigative study results, the Podcast will provide insights into the ways in which various types of fat depots affect CMR, the role of adipose tissue as an endocrine organ, and ways to assess and monitor changes in patients’ IAA.
	New Pathways to Cardiometabolic Risk: The Endocannabinoid System (ECS) This Podcast will present evidence that overactivity of the ECS-in adipose tissue, liver, skeletal muscle, and brain-can lead to the development of cardiometabolic risk factors, including increased intra-abdominal adiposity (IAA) and insulin resistance. Gaining insights into the role of the ECS can help you identify, manage, and monitor patients who are at risk for cardiovascular disease and diabetes.
	The Cardiometabolic Condition Site, where you’ll find valuable and current information about IAA, the ECS, and CMR from a variety of perspectives.